Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Conexeu Sciences Inc. (CNXU)

2.5400 -0.2900 (-10.25%)
At close: October 30 at 4:00:01 PM EDT
2.6448 +0.1048 (+4.13%)
After hours: October 30 at 6:18:23 PM EDT

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Miles D. Harrison
President, CEO & Director 23.72k -- 1965
Mr. David R. Bogart
Founder, Chief Commercial Officer & Director 110k -- 1970
Dr. Claudia Chavez-Munoz M.D., Ph.D.
Founder & Chief Scientific Officer 100k -- 1980
Mr. Stephen D. Inouye
CFO, Corporate Secretary & Treasurer 47.2k -- 1961
Dr. Brian K. Pilcher Ph.D.
Chief Medical Officer 127.5k -- 1969
Ms. Sonia Thomas M.B.A.
Head of Strategy & Transformation -- -- --
Mr. Jean-Romain Falconne
Head of Business Development & Licensing -- -- --

Conexeu Sciences Inc.

50 West Liberty Street
Suite 880
Reno, NV 89501
United States
(604) 315-4722 https://www.conexeu.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.

Corporate Governance

Conexeu Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

January 22, 2027 at 9:00 PM UTC

Conexeu Sciences Inc. Earnings Date

Recent Events

October 27, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 21, 2026 at 12:00 AM UTC

D: Additional Forms

October 20, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 29, 2026 at 12:00 AM UTC

D: Additional Forms

September 15, 2026 at 12:00 AM UTC

D: Additional Forms

September 14, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

September 10, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 31, 2026 at 12:00 AM UTC

D: Additional Forms

July 31, 2026 at 12:00 AM UTC

D: Additional Forms

July 7, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: